CREATE AN ACCOUNT
The Immune Tolerance Network (ITN) is an international clinical research consortium sponsored by NIAID, part of the National Institutes of Health. ITN's mission is to advance the clinical application of immune tolerance therapies and biomarker development by performing high quality clinical trials of emerging therapeutics integrated with mechanism-based research with a focus on allergy & asthma, organ transplantation, and autoimmune disease including Type 1 diabetes.
ITN TrialShare shares information about ITN's clinical studies and specimen bio-repository with the scientific research community. Data and analysis code underlying ITN-published manuscripts are publicly available with the goal of promoting transparency, reproducibility, and scientific collaboration.
Sample Sharing: The ITN also has thousands of biological specimens from clinically well-phenotyped study participants that are available for investigators to request for their own research. An inventory of the available samples and information about submitting a request for specimens are available on ITN TrialShare.
Bio-IT World Best Practices Awards
TrialShare featured in Clinical Informatics News
ITN’s TrialShare wins Honorable Mention at Bio-IT World Best Practices Awards.
MOST VIEWED STUDIES
|Immune Tolerance Network||Help||Home|
|About Us||Terms||Privacy||Contact||Quick Start Guide||User Guide|
|© Immune Tolerance Network|